[Advances in SARS-CoV-2 diagnostic strategies during the later COVID-19 era].
Zhonghua Jie He He Hu Xi Za Zhi
; 45(8): 819-825, 2022 Aug 12.
Article
en Zh
| MEDLINE
| ID: mdl-35927053
ABSTRACT
Based on natural infection or vaccination, the protective barrier for population has been preliminarily established. However, with constant appearances of SARS-CoV-2 variants, breakthrough infection events cannot be completely avoided, and thus the diagnostic strategy is still the key to discovering epidemic sources and blocking the transmission chain. Currently, SARS-CoV-2 diagnosis technologies based on nucleic acid, antigen and antibody detections have developed and extended in diversity. Under the background of work resumption and epidemic-prevention normalization during the later COVID-19 era, it is necessary for us to choose appropriate detection methods to satisfy the need of epidemic prevention and control in various scenarios. We summarized the principles and applicable characteristics of existing SARS-CoV-2 detection technologies in this paper, aimed to provide guidance for clinical and public health personnel to make targeted decisions.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Epidemias
/
COVID-19
Tipo de estudio:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Límite:
Humans
Idioma:
Zh
Año:
2022
Tipo del documento:
Article